Two large 'real-world' studies conducted in Germany and the USA have confirmed the high rates of sustained virological response (SVR) observed in controlled clinical studies of glecaprevir/pibrentasvir (G/P) involving individuals ...
Apr 12, 2019
0
1
Between 10 and 20 million people worldwide are infected with hepatitis D virus (HDV). HDV infection is always associated with hepatitis B virus infection. So far there has been no satisfactory therapeutic option for this ...
Oct 3, 2022
0
49
Despite the fact that hepatitis C virus (HCV) persists chronically in about 80 percent of those infected, some liver cells remain free of the virus even after many years. Now Sung Key Jang of Pohang University of Science ...
Sep 19, 2011
0
0
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa. The research from the Wellcome Sanger Institute, the MRC-University ...
Dec 17, 2018
0
3
Whole genome sequencing technology can discover various known or unspecified viral sequences contained in human blood, which can provide an important database for viral infection prevention, vaccine development, viral genomic ...
Dec 7, 2022
0
18
More than 70 million people worldwide are infected with hepatitis C. The disease is treatable, but it is often not recognized. In 80% of cases, it takes chronic courses and can lead to liver damage and even liver cancer. ...
Mar 2, 2022
0
12
Scientists at the University of Liverpool have demonstrated that a drug for treating hepatitis B virus (HBV) could be mass-produced for only £24 ($36) per person per year, versus the current UK NHS price of £4,600, and ...
Apr 22, 2015
0
23
(Medical Xpress)—Researchers at Kanazawa University Graduate School of Medical Science in Japan have determined how APOBEC proteins mediate hypermutations that inhibit viral replication. They also identify the host factor ...
Jun 25, 2013
0
0
Results presented today at The International Liver Congress 2015 show that a 12-week oral regimen of once-daily single tablet grazoprevir/elbasvir (GZR/EBR) is effective and well-tolerated in treatment-naive (TN) patients ...
Apr 24, 2015
0
4
Cancer myths irritate me. Not only because they fly in the face of scientific research, but also because they prey upon people who are just trying to do their best to live a healthy life.
Nov 7, 2019
0
2
